Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oleoylethanolamide treatment affects gut microbiota composition and the expression of intestinal cytokines in Peyer’s patches of mice
Monica Di Paola, Elena Bonechi, Gustavo Provensi, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Update on Anti-Inflammatory Molecular Mechanisms Induced by Oleic Acid
Consuelo Santa‐María, Soledad López, Sergio Montserrat‐de la Paz, et al.
Nutrients (2023) Vol. 15, Iss. 1, pp. 224-224
Open Access | Times Cited: 103
Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease
Nadine Fornelos, Eric A. Franzosa, Jason Bishai, et al.
Nature Microbiology (2020) Vol. 5, Iss. 3, pp. 486-497
Open Access | Times Cited: 83
Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse
Laura Orío, Francisco Alén, Francisco Javier Pavón, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 11
Open Access | Times Cited: 79
Beneficial Effects of Probiotic Bifidobacterium longum in a Lithium–Pilocarpine Model of Temporal Lobe Epilepsy in Rats
О. Е. Зубарева, A. V. Dyomina, Anna A. Kovalenko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8451-8451
Open Access | Times Cited: 23
The gut microbiome, endocannabinoids and metabolic disorders
Fabio Arturo Iannotti, Vincenzo Di Marzo
Journal of Endocrinology (2020) Vol. 248, Iss. 2, pp. R83-R97
Open Access | Times Cited: 64
The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
Vincenzo Di Marzo
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 259-269
Open Access | Times Cited: 61
Cross-Talk Between Gut Microbiota and Adipose Tissues in Obesity and Related Metabolic Diseases
Dan Wu, Huiying Wang, Lijun Xie, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 33
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 28
A Polysaccharide Isolated from Codonopsis pilosula with Immunomodulation Effects Both In Vitro and In Vivo
Yuanfeng Zou, Yanyun Zhang, Yuping Fu, et al.
Molecules (2019) Vol. 24, Iss. 20, pp. 3632-3632
Open Access | Times Cited: 52
A systematic review of the effects of oleoylethanolamide, a high‐affinity endogenous ligand of PPAR‐α, on the management and prevention of obesity
Helda Tutunchi, Maryam Saghafi‐Asl, Alireza Ostadrahimi
Clinical and Experimental Pharmacology and Physiology (2019) Vol. 47, Iss. 4, pp. 543-552
Open Access | Times Cited: 47
Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19
Samad Ghaffari, Neda Roshanravan, Helda Tutunchi, et al.
Archives of Medical Research (2020) Vol. 51, Iss. 5, pp. 464-467
Open Access | Times Cited: 46
(Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders
Jyoti Sihag, Vincenzo Di Marzo
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Gut microbiota and oleoylethanolamide in the regulation of intestinal homeostasis
Carlotta De Filippo, Alessia Costa, Maria Vittoria Becagli, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13
The PPAR-α agonist oleoyethanolamide (OEA) ameliorates valproic acid-induced steatohepatitis in rats via suppressing Wnt3a/β-catenin and activating PGC-1α: Involvement of network pharmacology and molecular docking
Maram Mohammed El Tabaa, Heba Faheem, Mohammed S. Elballal, et al.
European Journal of Pharmacology (2025), pp. 177306-177306
Closed Access
Oleoylethanolamide-producing Lactobacillus paracasei F19 improves metabolic and behavioral disorders by restoring intestinal permeability and microbiota-gut-brain axis in high-fat diet-induced obese male mice
Luisa Seguella, Chiara Corpetti, Jie Lu, et al.
Brain Behavior and Immunity (2025)
Closed Access
Sustainable synthesis, process optimization, and industrial applications of oleic ethanolamide
Ghislaine M. Ndonkeu, Egi Agustian, Joseph Blaise L. Dongmo, et al.
Biomass Conversion and Biorefinery (2025)
Closed Access
The anti-inflammatory and immune-modulatory effects of OEA limit DSS-induced colitis in mice
Adriano Lama, Gustavo Provensi, Roberta Amoriello, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110368-110368
Open Access | Times Cited: 37
Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and Wellbeing
Enrico Gugliandolo, Alessio Filippo Peritore, Cristian Piras, et al.
Veterinary Sciences (2020) Vol. 7, Iss. 2, pp. 78-78
Open Access | Times Cited: 33
Metabolomics activity screening of T cell–induced colitis reveals anti-inflammatory metabolites
J. Rafael Montenegro-Burke, Bernard P. Kok, Carlos Guijas, et al.
Science Signaling (2021) Vol. 14, Iss. 702
Open Access | Times Cited: 28
Gut-liver axis modulation in fructose-fed mice: a role for PPAR-alpha and linagliptin
Flávia Maria Silva-Veiga, Carolline Santos Miranda, Fabiane Ferreira Martins, et al.
Journal of Endocrinology (2020) Vol. 247, Iss. 1, pp. 11-24
Open Access | Times Cited: 30
The emerging role of the endocannabinoidome-gut microbiome axis in eating disorders
Hayatte-Dounia Mir, Giada Giorgini, Vincenzo Di Marzo
Psychoneuroendocrinology (2023) Vol. 154, pp. 106295-106295
Closed Access | Times Cited: 10
Social stress-induced depressive-like symptoms and changes in gut microbial and lipidomic profiles are prevented by pharmacological inhibition of FAAH activity in male rats
Margherita Barbetti, Leonardo Mancabelli, Federica Vacondio, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 131, pp. 110963-110963
Open Access | Times Cited: 3
Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint
Aniello Schiano Moriello, Vincenzo Di Marzo, Stefania Petrosino
Animals (2022) Vol. 12, Iss. 3, pp. 348-348
Open Access | Times Cited: 15
Microbiota and Alcohol Use Disorder: Are Psychobiotics a Novel Therapeutic Strategy?
Alicia Rodríguez‐González, Laura Orío
Current Pharmaceutical Design (2020) Vol. 26, Iss. 20, pp. 2426-2437
Closed Access | Times Cited: 21
A high docosahexaenoic acid diet alters lung inflammation and recovery following repetitive exposure to aqueous organic dust extracts
Arzu Ulu, Abigail Burr, Art J. Heires, et al.
The Journal of Nutritional Biochemistry (2021) Vol. 97, pp. 108797-108797
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top